These results indicate that BACE1-mediated Aβ accumulation starts many years before the onset of AD, thus advocating the promising role of BACE1 as a reliable biomarker for early detection of AD, especially in serum (Cervellati et al., 2020). Here, BACE1 is linked to Alzheimer disease.